Document is current
Any future updates will be listed below
-
Authors
Bravo, Rafael https://orcid.org/0000-0001-6732-2205
Lee, Kyung Hyun https://orcid.org/0000-0003-2475-5814
Nazeer, Sarah A.
Cornthwaite, Jocelyn A.
Fishel Bartal, Michal
Pedroza, Claudia
- License Information
-
More Information
Article History
Received: 7 December 2023
Revised: 3 September 2024
Accepted: 12 September 2024
First Online: 18 September 2024
Competing interests
: Previously, JAC held stocks in Dexcom, Inc. at the start of a previous study but has since divested all shares. In this new study, JAC did not hold any stocks in Dexcom, Inc. during its conceptualization or execution. All other authors declare no conflict of interest.
: The Institutional Review Board approved the protocol at the McGovern Medical School (HSC-MS-18-0774) for the previous publication []. Since this study was conceptualized as a reanalysis with a different approach no new approval was required.
